Research
Oncology
Free radical kinetics offer insight into cancer metabolism, treatment response, and metastatic potential, enabling real-time, subcellular oncology diagnostics.
Proof points
Diazoxide treatment
Cancer cells exhibited increased oxidative stress upon treatment. Enables real-time monitoring of free radical based drug efficacy.
NOX2 inhibition
Inhibition led to elevated free radical levels and reduced cell migration. Validates redox targeting in anti-metastatic strategies.
Colon cancer differentiation
Oxidative stress levels decreased during cellular redifferentiation. Predicts treatment-driven tumor normalization.
Advantages & complementarity
- Monitors tumor oxidative stress dynamics
- Complements histopathology and genomic testing
- Assesses drug response in real time
- Quantifies metastasis-linked ROS production
- Maps therapy-resistant cellular zones
Partnership opportunities
We welcome collaborations with oncology researchers and drug developers working on free radical modulating agents, immunotherapies, radiation sensitizers, or tumor metabolism interventions. Our biomarker can support mechanism-of-action studies and patient stratification.
Share this:
